InsiderSource

Zaks Tal Zvi

Director, Chief Medical Officer · SEC CIK 1690927
Insider at TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD ADAP Adaptimmune Therapeutics PLC MRNA Moderna, Inc.
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.73M
157 trades
Net flow
−$28.73M
Net selling
Total filings
199
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −51%

Zaks Tal Zvi sold $341.4K of MRNA, trimming their stake 51%.

−$341.4K
2,611 sh @ $131
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −81%

Zaks Tal Zvi sold $263.7K of MRNA, trimming their stake 81%.

−$263.7K
2,000 sh @ $132
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −100%

Zaks Tal Zvi sold $62.6K of MRNA, trimming their stake 100%.

−$62.6K
471 sh @ $133
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 2, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 2, 2021 ΔOwn +100%
+$71.1K
5,000 sh @ $14
Advertisement
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −22%

Zaks Tal Zvi sold $322.8K of MRNA, trimming their stake 22%.

−$322.8K
2,201 sh @ $147
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −25%

Zaks Tal Zvi sold $293.4K of MRNA, trimming their stake 25%.

−$293.4K
1,986 sh @ $148
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −12%

Zaks Tal Zvi sold $104.3K of MRNA, trimming their stake 12%.

−$104.3K
700 sh @ $149
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −20%

Zaks Tal Zvi sold $155.6K of MRNA, trimming their stake 20%.

−$155.6K
1,039 sh @ $150
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −15%

Zaks Tal Zvi sold $90.5K of MRNA, trimming their stake 15%.

−$90.5K
600 sh @ $151
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −26%

Zaks Tal Zvi sold $136.8K of MRNA, trimming their stake 26%.

−$136.8K
900 sh @ $152
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −29%

Zaks Tal Zvi sold $116.2K of MRNA, trimming their stake 29%.

−$116.2K
753 sh @ $154
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −33%

Zaks Tal Zvi sold $93.4K of MRNA, trimming their stake 33%.

−$93.4K
600 sh @ $156
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −63%

Zaks Tal Zvi sold $120.7K of MRNA, trimming their stake 63%.

−$120.7K
771 sh @ $156
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 2, 2021 ΔOwn −100%

Zaks Tal Zvi sold $70.8K of MRNA, trimming their stake 100%.

−$70.8K
450 sh @ $157
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Feb 24, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −5.3%

Zaks Tal Zvi sold $41.9K of MRNA, trimming their stake 5%.

−$41.9K
263 sh @ $159
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −2.1%

Zaks Tal Zvi sold $16K of MRNA, trimming their stake 2%.

−$16K
100 sh @ $160
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −17%

Zaks Tal Zvi sold $130K of MRNA, trimming their stake 17%.

−$130K
800 sh @ $162
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −29%

Zaks Tal Zvi sold $179.9K of MRNA, trimming their stake 29%.

−$179.9K
1,100 sh @ $164
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −11%

Zaks Tal Zvi sold $49.4K of MRNA, trimming their stake 11%.

−$49.4K
300 sh @ $165
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −41%

Zaks Tal Zvi sold $166K of MRNA, trimming their stake 41%.

−$166K
1,000 sh @ $166
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −49%

Zaks Tal Zvi sold $116.8K of MRNA, trimming their stake 49%.

−$116.8K
700 sh @ $167
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −48%

Zaks Tal Zvi sold $59.8K of MRNA, trimming their stake 48%.

−$59.8K
356 sh @ $168
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −74%

Zaks Tal Zvi sold $47.5K of MRNA, trimming their stake 74%.

−$47.5K
281 sh @ $169
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 24, 2021 ΔOwn −100%

Zaks Tal Zvi sold $17K of MRNA, trimming their stake 100%.

−$17K
100 sh @ $170
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Feb 9, 2021 ΔOwn NEW
+$44.8K
3,670 sh @ $12
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −2.7%

Zaks Tal Zvi sold $17.8K of MRNA, trimming their stake 3%.

−$17.8K
100 sh @ $178
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −8.4%

Zaks Tal Zvi sold $53.8K of MRNA, trimming their stake 8%.

−$53.8K
300 sh @ $179
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −3.1%

Zaks Tal Zvi sold $18.1K of MRNA, trimming their stake 3%.

−$18.1K
100 sh @ $181

Frequently asked questions

How is Zaks Tal Zvi's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Zaks Tal Zvi's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.